MENU
+Compare
CAPR
Stock ticker: NASDAQ
AS OF
Mar 28 closing price
Price
$11.50
Change
-$0.31 (-2.62%)
Capitalization
539.66M

CAPR Capricor Therapeutics Forecast, Technical & Fundamental Analysis

Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases... Show more

Industry: #Biotechnology
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CAPR with price predictions
Mar 28, 2025

CAPR in +4.82% Uptrend, rising for three consecutive days on March 25, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CAPR advanced for three days, in of 270 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CAPR as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CAPR turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at .

CAPR moved below its 50-day moving average on March 21, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CAPR crossed bearishly below the 50-day moving average on March 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAPR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CAPR broke above its upper Bollinger Band on March 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CAPR entered a downward trend on March 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CAPR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.611) is normal, around the industry mean (14.018). P/E Ratio (0.000) is within average values for comparable stocks, (64.861). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.895). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (18.182) is also within normal values, averaging (257.773).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CAPR is expected to report earnings to rise 68.75% to -27 cents per share on May 08

Capricor Therapeutics CAPR Stock Earnings Reports
Q1'25
Est.
$-0.27
Q4'24
Beat
by $0.01
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.08
The last earnings report on March 19 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 1.19M shares outstanding, the current market capitalization sits at 539.66M.
A.I. Advisor
published General Information

General Information

Develops innovative products for the treatment of cardiovascular diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
10865 Road to the Cure
Phone
+1 858 727-1755
Employees
102
Web
https://www.capricor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSVIX27.13N/A
N/A
Transamerica Small/Mid Cap Value I
HOORX28.09N/A
N/A
Hartford Schroders US Small Cap Opps R3
CDIVX11.59N/A
N/A
Copeland Dividend Growth Fund Class I
ACAZX33.38N/A
N/A
Alger Capital Appreciation Z
NPNRX46.48N/A
N/A
Neuberger Berman Large Cap Value R3

CAPR and Stocks

Correlation & Price change

A.I.dvisor tells us that CAPR and SRPT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and SRPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
-2.67%
SRPT - CAPR
32%
Poorly correlated
-1.95%
MDGL - CAPR
30%
Poorly correlated
-2.79%
CORT - CAPR
30%
Poorly correlated
-3.62%
RCKT - CAPR
29%
Poorly correlated
-3.68%
SLNO - CAPR
28%
Poorly correlated
+6.83%
More